chr10-110781370-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001134363.3(RBM20):c.761C>T(p.Ser254Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000284 in 1,551,718 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.761C>T | p.Ser254Leu | missense_variant | 2/14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.596C>T | p.Ser199Leu | missense_variant | 2/14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.377C>T | p.Ser126Leu | missense_variant | 2/14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.377C>T | p.Ser126Leu | missense_variant | 2/14 | XP_047281072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM20 | ENST00000369519.4 | c.761C>T | p.Ser254Leu | missense_variant | 2/14 | 1 | NM_001134363.3 | ENSP00000358532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152252Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000325 AC: 5AN: 153878Hom.: 0 AF XY: 0.0000367 AC XY: 3AN XY: 81664
GnomAD4 exome AF: 0.0000172 AC: 24AN: 1399348Hom.: 0 Cov.: 32 AF XY: 0.0000188 AC XY: 13AN XY: 690186
GnomAD4 genome AF: 0.000131 AC: 20AN: 152370Hom.: 1 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74516
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 1DD Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 09, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 25, 2022 | Variant summary: RBM20 c.761C>T (p.Ser254Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 153878 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.761C>T has been reported in the literature in at least one individual without clinical information. This report does not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. Co-occurrences with a pathogenic variant has been reported (TTR c.424G>A, p.Val142Ile), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2023 | The p.S254L variant (also known as c.761C>T), located in coding exon 2 of the RBM20 gene, results from a C to T substitution at nucleotide position 761. The serine at codon 254 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at